Literature DB >> 26687854

PET Neurochemical Imaging Modes.

Michael S Placzek1, Wenjun Zhao2, Hsiao-Ying Wey2, Thomas M Morin3, Jacob M Hooker4.   

Abstract

PET has deep roots in neuroscience stemming from its first application in brain tumor and brain metabolism imaging. PET emerged over the past few decades and continues to play a prominent role in the study of neurochemistry in the living human brain. Over time, neurochemical imaging with PET has been expanded to address a host of research questions related to, among many others, protein density, drug occupancy, and endogenous neurochemical release. Each of these imaging modes has distinct design and analysis considerations that are critical for enabling quantitative measurements. The number of considerations required for a neurochemical PET study can make it unapproachable. This article aims to orient those interested in neurochemical PET imaging to three of the common imaging modes and to provide some perspective on needs that exist for expansion of neurochemical PET imaging.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26687854      PMCID: PMC5709996          DOI: 10.1053/j.semnuclmed.2015.09.001

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  63 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Effects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice.

Authors:  O V Rice; S J Gatley; J Shen; C L Huemmer; R Rogoz; O T DeJesus; N D Volkow; A N Gifford
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

3.  Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.

Authors:  A A Wilson; N Ginovart; M Schmidt; J H Meyer; P G Threlkeld; S Houle
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

4.  Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.

Authors:  Matthew S Milak; R Todd Ogden; Daniel N Vinocur; Ronald L Van Heertum; Thomas B Cooper; J John Mann; Ramin V Parsey
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

5.  Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.

Authors:  Peter S Talbot; W Gordon Frankle; Dah-Ren Hwang; Yiyun Huang; Raymond F Suckow; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle
Journal:  Synapse       Date:  2005-03-01       Impact factor: 2.562

6.  Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.

Authors:  Boris B Quednow; Valerie Treyer; Felix Hasler; Nadja Dörig; Matthias T Wyss; Cyrill Burger; Katharina M Rentsch; Gerrit Westera; Pius August Schubiger; Alfred Buck; Franz X Vollenweider
Journal:  Neuroimage       Date:  2011-10-05       Impact factor: 6.556

7.  Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.

Authors:  Stefano Marenco; Richard E Carson; Karen Faith Berman; Peter Herscovitch; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

8.  In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.

Authors:  Alan A Wilson; Nathalie Ginovart; Doug Hussey; Jeff Meyer; Sylvain Houle
Journal:  Nucl Med Biol       Date:  2002-07       Impact factor: 2.408

Review 9.  Application of cross-species PET imaging to assess neurotransmitter release in brain.

Authors:  Sjoerd J Finnema; Mika Scheinin; Mohammed Shahid; Jussi Lehto; Edilio Borroni; Benny Bang-Andersen; Jukka Sallinen; Erik Wong; Lars Farde; Christer Halldin; Sarah Grimwood
Journal:  Psychopharmacology (Berl)       Date:  2015-04-30       Impact factor: 4.530

10.  Detection of dopamine neurotransmission in "real time".

Authors:  Rajendra D Badgaiyan
Journal:  Front Neurosci       Date:  2013-07-18       Impact factor: 4.677

View more
  3 in total

1.  Direct 11CN-Labeling of Unprotected Peptides via Palladium-Mediated Sequential Cross-Coupling Reactions.

Authors:  Wenjun Zhao; Hong Geun Lee; Stephen L Buchwald; Jacob M Hooker
Journal:  J Am Chem Soc       Date:  2017-05-17       Impact factor: 15.419

Review 2.  Understanding Peripartum Depression Through Neuroimaging: a Review of Structural and Functional Connectivity and Molecular Imaging Research.

Authors:  Christy Duan; Jessica Cosgrove; Kristina M Deligiannidis
Journal:  Curr Psychiatry Rep       Date:  2017-08-19       Impact factor: 5.285

3.  Imaging cardiac SCN5A using the novel F-18 radiotracer radiocaine.

Authors:  Jacob M Hooker; Martin G Strebl; Frederick A Schroeder; Hsiao-Ying Wey; Amrut V Ambardekar; Timothy A McKinsey; Matthias Schoenberger
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.